Skip to the page

Data / Medical devices / United States / Medibeacon Inc.

Medibeacon Inc.: FDA-registered device maker in Creve Coeur, MO, United States, 1 PMA approval

Medibeacon Inc. is registered with the FDA (registration 3027576156) in Creve Coeur, MO, United States. It lists 1 device type. The FDA files 1 PMA approval under its listings, the newest dated January 17, 2025. Registered through 2026. FDA data exported November 2, 2026.

SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.

FDA registration number
3027576156
Address
425 N New Ballas Rd Ste 100, Creve Coeur, MO, United States, 63141
Owner or operator
MediBeacon Inc. (10095100)
Roles
Specification developer
First device listed
January 23, 2026
Registered through
2026
Brand names listed
Lumitrace (relmapirazin) Injection, MediBeacon TGFR Disposable Ring, MediBeacon TGFR Monitor, MediBeacon TGFR Reusable Sensor, MediBeacon Transdermal GFR System

Devices it lists

DeviceProduct codeClassRoleSource
Transdermal Test For Assessment Of Glomerular Filtration RateSDK3Specification developeraccessdata.fda.gov

PMA approvals

Premarket approvals this establishment lists, with the supplements the FDA has decided since.

ApprovedPMA numberDeviceProduct codeSupplementsLatest decisionSource
January 17, 2025P230019MediBeacon® Transdermal GFR Measurement System (TGFR)SDK4October 2, 2026accessdata.fda.gov

Compare with other makers

Updated October 2, 2026. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.